Anjui Wu

Anjui Wu

University College London

H-index: 9

Europe-United Kingdom

About Anjui Wu

Anjui Wu, With an exceptional h-index of 9 and a recent h-index of 9 (since 2020), a distinguished researcher at University College London, specializes in the field of Cancer Biology, cfDNA.

His recent articles reflect a diverse array of research interests and contributions to the field:

Prostate cancer detection methods

Accidentals of the DNA Symphony

Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges

Outcomes of the SARS-CoV-2 omicron (B. 1.1. 529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre …

Mortality among adults with cancer undergoing chemotherapy or immunotherapy and infected with COVID-19

1575P Systemic anti-cancer therapy and metastatic cancer are independent mortality risk factors during two UK waves of the COVID-19 pandemic at University College London Hospital

Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective

Systemic anti-cancer therapy and metastatic cancer are independent mortality risk factors during two UK waves of the COVID-19 pandemic at university college london hospital

Anjui Wu Information

University

Position

___

Citations(all)

1101

Citations(since 2020)

981

Cited By

296

hIndex(all)

9

hIndex(since 2020)

9

i10Index(all)

9

i10Index(since 2020)

9

Email

University Profile Page

Google Scholar

Anjui Wu Skills & Research Interests

Cancer Biology

cfDNA

Top articles of Anjui Wu

Prostate cancer detection methods

2022/12/1

Accidentals of the DNA Symphony

Cancer Research

2022/11/2

Anjui Wu
Anjui Wu

H-Index: 5

Gerhardt Attard
Gerhardt Attard

H-Index: 54

Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges

2022/11/1

1575P Systemic anti-cancer therapy and metastatic cancer are independent mortality risk factors during two UK waves of the COVID-19 pandemic at University College London Hospital

Annals of Oncology

2021/9/1

Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective

Therapeutic Advances in Medical Oncology

2021/8/23

Systemic anti-cancer therapy and metastatic cancer are independent mortality risk factors during two UK waves of the COVID-19 pandemic at university college london hospital

Cancers

2021/12

Cancer history and systemic anti-cancer therapy independently predict COVID-19 mortality: a UK tertiary hospital experience

Frontiers in Oncology

2020/11

1704P COVID-19 mortality in patients receiving anti-cancer therapy in a UK national cancer centre

Annals of Oncology

2020/9/1

1734P Do cancer patients really do worse? A study in a UK tertiary hospital within a COVID-19 epicentre

Annals of Oncology

2020/9/1

Genome-wide plasma DNA methylation features of metastatic prostate cancer

The Journal of clinical investigation

2020/6/15

Circulating cell-free DNA methylation analysis of metastatic prostate cancer

2020/3/31

Anjui Wu
Anjui Wu

H-Index: 5

See List of Professors in Anjui Wu University(University College London)